Study aid only. Verify against current guidelines, primary literature, staging manuals, and prescribing information before clinical use.

← All algorithms  ·  Related notes →

Localized Prostate Cancer — Management by Risk Group

Localized prostate cancer by risk group Low risk Favorable intermediate Unfavorable intermediate High / very-high risk Preferred Active surveillance monitor PSA / MRI / biopsy Option Active surveillance or RT / prostatectomy Radiation RT + short-term ADT 4–6 months Surgery Radical prostatectomy + pelvic LND if indicated Radiation RT + long-term ADT ± abiraterone STAMPEDE ↗ Surgery Radical prostatectomy + LND multimodal